November 21 is World Pancreatic Cancer Day – a day to raise awareness about a silent but deadly disease. Recognizing the symptoms early can make a difference. Here are seven common symptoms to watch for: ?? Pain in Your Back or Stomach Persistent pain in the abdomen or mid-back may be caused by a tumor pressing on nerves or nearby organs. ?? Bloating Pancreatic cancer can lead to digestive issues, gas, bloating, and even ascites (fluid build-up in the abdomen), causing a swollen belly. ?? Trouble Digesting Food Loss of appetite, nausea, and indigestion are common. These symptoms may signal the cancer is affecting digestion and nutrient absorption. ?? Unexplained Weight Loss Losing weight without a clear reason? This could be due to cancer affecting digestion or metabolic changes that increase calorie burning and muscle breakdown. Learn more and protect your health: https://pancan.org/ If you or someone you know is experiencing these symptoms, speak with a healthcare provider. #WorldPancreaticCancerDay #PancreaticCancerAwareness #HealthAwareness #EarlyDetectionMatters #marincommunityclinics
Marin Community Clinics的动态
最相关的动态
-
Health is Wealth ! Nov 21, Pancreatic Cancer Awareness day #pancreas #awareness #healthiswealth Is important to recognize it . Common symptoms of pancreatic cancer can include: ??Jaundice: Yellowing of the skin and eyes due to bile duct obstruction. ??Abdominal Pain: Often felt in the upper abdomen and may radiate to the back. ??Unexplained Weight Loss: Losing weight without trying can be a significant symptom. ??Loss of Appetite: A decrease in hunger or interest in food. ??Nausea and Vomiting: Feeling sick to the stomach or vomiting can occur. ??New Onset Diabetes: Developing diabetes, especially in older adults, can be a sign. ??Fatigue: Persistent tiredness or weakness that doesn't improve with rest. If you or someone you know is experiencing these symptoms, it's important to consult a healthcare professional for further evaluation. Source of the image https://lnkd.in/gPdw5ssJ
要查看或添加评论,请登录
-
-
According to the American Diabetes Association, liver disease affects up to 70% of those with Type 2 diabetes. If you live with Type 2 diabetes, you may be at risk for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition that can lead to cirrhosis, liver cancer and heart disease. The good news is that knowing your risk can help you take control of the disease. To better understand your MASH risk and learn how you can manage it, talk to your provider about Labcorp’s testing solutions for fatty liver disease. Our comprehensive portfolio can help with diagnosis and management of MASH so you and your care team can make informed decisions for your health. Explore our profiles and related tests: https://lnkd.in/ebdV7C3s #DiabetesAwarenessMonth #MASH
要查看或添加评论,请登录
-
-
According to the American Diabetes Association, liver disease affects up to 70% of those with Type 2 diabetes. If you live with Type 2 diabetes, you may be at risk for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition that can lead to cirrhosis, liver cancer and heart disease. The good news is that knowing your risk can help you take control of the disease. To better understand your MASH risk and learn how you can manage it, talk to your provider about Labcorp’s testing solutions for fatty liver disease. Our comprehensive portfolio can help with diagnosis and management of MASH so you and your care team can make informed decisions for your health. Explore our profiles and related tests: https://lnkd.in/esWU3usU #DiabetesAwarenessMonth #MASH
要查看或添加评论,请登录
-
-
According to the American Diabetes Association, liver disease affects up to 70% of those with Type 2 diabetes. If you live with Type 2 diabetes, you may be at risk for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition that can lead to cirrhosis, liver cancer and heart disease. The good news is that knowing your risk can help you take control of the disease. To better understand your MASH risk and learn how you can manage it, talk to your provider about Labcorp’s testing solutions for fatty liver disease. Our comprehensive portfolio can help with diagnosis and management of MASH so you and your care team can make informed decisions for your health. Explore our profiles and related tests: https://lnkd.in/eehx7ZK3 #DiabetesAwarenessMonth #MASH
要查看或添加评论,请登录
-
-
According to the American Diabetes Association, liver disease affects up to 70% of those with Type 2 diabetes. If you live with Type 2 diabetes, you may be at risk for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition that can lead to cirrhosis, liver cancer and heart disease. The good news is that knowing your risk can help you take control of the disease. To better understand your MASH risk and learn how you can manage it, talk to your provider about Labcorp’s testing solutions for fatty liver disease. Our comprehensive portfolio can help with diagnosis and management of MASH so you and your care team can make informed decisions for your health. Explore our profiles and related tests: #DiabetesAwarenessMonth #MASH
要查看或添加评论,请登录
-
-
According to the American Diabetes Association, liver disease affects up to 70% of those with Type 2 diabetes. If you live with Type 2 diabetes, you may be at risk for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition that can lead to cirrhosis, liver cancer and heart disease. The good news is that knowing your risk can help you take control of the disease. To better understand your MASH risk and learn how you can manage it, talk to your provider about Labcorp’s testing solutions for fatty liver disease. Our comprehensive portfolio can help with diagnosis and management of MASH so you and your care team can make informed decisions for your health. Explore our profiles and related tests: https://lnkd.in/ebd6qv7q #DiabetesAwarenessMonth #MASH
要查看或添加评论,请登录
-
-
According to the American Diabetes Association, liver disease affects up to 70% of those with Type 2 diabetes. If you live with Type 2 diabetes, you may be at risk for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition that can lead to cirrhosis, liver cancer and heart disease. The good news is that knowing your risk can help you take control of the disease. To better understand your MASH risk and learn how you can manage it, talk to your provider about Labcorp’s testing solutions for fatty liver disease. Our comprehensive portfolio can help with diagnosis and management of MASH so you and your care team can make informed decisions for your health. Explore our profiles and related tests: #DiabetesAwarenessMonth #MASH
要查看或添加评论,请登录
-
-
Emerging research strongly links chronic inflammation to a wide range of chronic diseases, including: - Heart disease: Inflammation contributes to plaque buildup in arteries, leading to heart attacks and strokes. - Type 2 diabetes: Chronic inflammation impairs insulin resistance, a key factor in developing type 2 diabetes. ? - Autoimmune diseases: Conditions like rheumatoid arthritis and lupus are characterized by chronic inflammation. ? - Cancer: Inflammation can create a favorable environment for cancer cell growth and spread. ? - Digestive issues: Inflammatory bowel diseases like Crohn's disease and ulcerative colitis are directly linked to chronic inflammation. Remember: It's essential to consult with a healthcare professional for personalized advice and to address any underlying health concerns. Would you like to delve deeper into a specific chronic disease or explore anti-inflammatory foods and recipes? Contact me through DM, link on my bio, or email me at [email protected]. Let's transform your health for holistic healing! #chronicinflammation #healthandwellnesscoach #NewZealand
要查看或添加评论,请登录
-
-
According to the American Diabetes Association, liver disease affects up to 70% of those with Type 2 diabetes. If you live with Type 2 diabetes, you may be at risk for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition that can lead to cirrhosis, liver cancer and heart disease. The good news is that knowing your risk can help you take control of the disease. To better understand your MASH risk and learn how you can manage it, talk to your provider about Labcorp’s testing solutions for fatty liver disease. Our comprehensive portfolio can help with diagnosis and management of MASH so you and your care team can make informed decisions for your health. Explore our profiles and related tests: https://lnkd.in/eH9cuBTc #DiabetesAwarenessMonth #MASH
要查看或添加评论,请登录
-
-
According to the American Diabetes Association, liver disease affects up to 70% of those with Type 2 diabetes. If you live with Type 2 diabetes, you may be at risk for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition that can lead to cirrhosis, liver cancer and heart disease. The good news is that knowing your risk can help you take control of the disease. To better understand your MASH risk and learn how you can manage it, talk to your provider about Labcorp’s testing solutions for fatty liver disease. Our comprehensive portfolio can help with diagnosis and management of MASH so you and your care team can make informed decisions for your health. Explore our profiles and related tests: https://lnkd.in/eW9FkfrV #DiabetesAwarenessMonth #MASH
要查看或添加评论,请登录
-